ArticleBMC infectious diseases2025
Automatic fluorescence microscopic image analyzer: a novel AI-based tool for early diagnosing superficial fungal infections.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Artificial Intelligence in the Diagnosis of Superficial Mycoses: A Scoping Review.Journal of fungi (Basel, Switzerland) · 2026Review
- Retrospective Epidemiological Analyses of 12,976 Culture-Positive Superficial Fungal Infections in Shanghai, East China.Mycoses · 2026Observational
- Advancements in Artificial Intelligence-Based Diagnostic Tools Used to Detect Fungal Infections: A Systematic Review.Diagnostics (Basel, Switzerland) · 2026Review
- Therapy-associated facial redness in atopic dermatitis: insights from a case series.Anais brasileiros de dermatologiaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundSuperficial fungal infections (SFIs) are highly prevalent globally, affecting approximately 20–25% of the population. Their diverse and often non-specific clinical manifestations necessitate accurate and timely laboratory diagnosis. Traditional methods such as potassium hydroxide (KOH) microscopy and fluorescence staining, although widely used, are limited by operator dependency, variability in sensitivity, and time-consuming procedures. To improve diagnostic accuracy and efficiency, we evaluated the performance of a novel Artificial Intelligence (AI) -powered Fluorescence Microscopic Image Analyzer (FMIA) in the early detection of SFIs.
resultsAmong 300 patients with suspected SFIs, 241 were confirmed using a comprehensive clinical and mycological reference standard. FMIA achieved the highest diagnostic sensitivity (96.27%), outperforming both fluorescence staining (92.95%) and KOH microscopy (75.52%). FMIA also demonstrated high specificity (96.61%) and an area under the ROC curve of 0.96. In spore-dominant infections such as Malassezia folliculitis, genital candidiasis, tinea capitis, and seborrheic dermatitis, where KOH microscopy showed lower detection rates ranging from 29 to 59%, FMIA achieved significantly higher sensitivities between 83% and 100%. Across various SFI subtypes, FMIA consistently exhibited excellent diagnostic performance, achieving 100% detection for tinea pedis, tinea manuum, tinea faciei, and pityriasis versicolor. The system provided results within three to five minutes at a low per-test cost, while automated focusing and frame validation effectively minimized false positives caused by artifacts.
conclusionsThe FMIA system offers a highly accurate, rapid, and cost-effective tool for diagnosing SFIs. By addressing the limitations of traditional microscopy and current AI-based image analysis methods, FMIA improves diagnostic precision and efficiency. Its fully automated workflow delivers significant clinical value for routine application in both high-throughput diagnostic laboratories and resource-limited healthcare settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.